Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Marathon Petroleum | MPC | Nov 13, 2024 | 159.11 | +2.51 |
Maravai LifeSciences A | MRVI | Nov 13, 2024 | 5.63 | -1.23 |
Marblegate Acquisition A | GATE | Nov 13, 2024 | 11.19 | 0.00 |
Marchex B | MCHX | Nov 13, 2024 | 1.75 | -6.91 |
Marcus | MCS | Nov 13, 2024 | 21.98 | -0.63 |
Marcus & Millichap | MMI | Nov 13, 2024 | 41.17 | +0.19 |
Marex Group | MRX | Nov 13, 2024 | 28.46 | -1.04 |
Marin Software | MRIN | Nov 13, 2024 | 2.05 | -0.49 |
Marine Petroleum Trust U | MARPS | Nov 13, 2024 | 3.91 | -1.26 |
Marine Products | MPX | Nov 13, 2024 | 9.86 | -0.80 |
MarineMax | HZO | Nov 13, 2024 | 30.82 | -0.03 |
Marinus Pharmaceuticals | MRNS | Nov 13, 2024 | 0.30 | -12.35 |
Maris-Tech | MTEK | Nov 13, 2024 | 1.86 | 0.00 |
Markel | MKL | Nov 13, 2024 | 1 655.36 | +0.05 |
Marker Therapeutics | MRKR | Nov 13, 2024 | 3.64 | -2.15 |
Market Vectors Bdc Income ETF | BIZD | Nov 13, 2024 | 16.31 | +0.43 |
Market Vectors Investment Grade | FLTR | Nov 13, 2024 | 25.46 | 0.00 |
Market Vectors Israel ETF | ISRA | Nov 13, 2024 | 41.13 | -0.05 |
Market Vectors Preferred Securi | PFXF | Nov 13, 2024 | 18.04 | +0.22 |
MarketAxess | MKTX | Nov 13, 2024 | 267.13 | -1.66 |
MarketWise A | MKTW | Nov 13, 2024 | 0.50 | -6.43 |
Markforged | MKFG | Nov 13, 2024 | 4.37 | -0.46 |
Marpai A | MRAI | Nov 13, 2024 | 1.94 | 0.00 |
Marqeta A | MQ | Nov 13, 2024 | 3.91 | -4.87 |
Marriott International A | MAR | Nov 13, 2024 | 286.47 | +0.16 |
Marriott Vacations Worldwide | VAC | Nov 13, 2024 | 92.70 | -1.24 |
Mars Acquisition | MARX | Nov 13, 2024 | 11.05 | 0.00 |
Mars Acquisition Units | MARXU | Nov 13, 2024 | 11.22 | 0.00 |
Marsh & McLennan Companies | MMC | Nov 13, 2024 | 225.73 | +0.25 |
Marten Tranport | MRTN | Nov 13, 2024 | 17.67 | -1.51 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.